Mr. Eng brings to D2, extensive career experiences in the health care industry that covers specialty pharmacy, payer and provider medical benefit drug management, group purchasing organization specialty distribution, specialty drug utilization management strategies, provider development, sales, marketing, business development and most recently, health care technology-based solutions.

Prior to D2, Mr. Eng had assumed increasing roles of leadership responsibilities for Onco360, CVS Caremark, CuraScript/ESI, Sicor, Fujisawa and Eli Lilly & Co.  A long history of bringing innovative approaches to solving complex health system challenges, Mr. Eng has also been published in numerous publications such as the Journal NCCN and Specialty Pharmacy Times, a task force member for a number of NCCN special projects (Specialty pharmacy and REMS) and frequent presenter at recognized industry conferences.